What this means
This is a trial that is still signing up people, so no results exist yet. It will look at whether the pill helps and find signs that show aging.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18–65
- Where
- 1 site
The science
- Registered title
- Pilot Study on Evaluating the Geroprotective Effect of Metformin
- Trial ID
- NCT06459310 ↗
- Phase
- PHASE 2
- Study type
- interventional
- Conditions
- Metformin, Aging
- What is tested
- Metformin Hydrochloride tablet, Placebo
- Sponsor
- Xuanwu Hospital, Beijing
- Ages
- 18 Years to 65 Years
- Dates
- First posted Jun 14, 2024 · updated Mar 21, 2025
Registry summary
The objective of this research is to assess the efficacy of oral metformin in mitigating the aging process in middle-aged and elderly males, to pinpoint sensitive indicators of human senescence, and to offer innovative frameworks and scientific insights for pharmaceutical interventions in aging.
Sites (1)
- Xuanwu Hospital Capital Medical University, Beijing, China